Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Thomas G. Wiggans currently holds 41,000 shares of ONYX PHARMACEUTICALS INC (ONXX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas G. Wiggans has been a net seller of ONXX stock. They have purchased $1.0M and sold $8.2M worth of shares.
Thomas G. Wiggans's most recent insider trade was on Sep 22, 2025, when they purchased 41,000 shares at $2.43 per share.
Thomas G. Wiggans serves as Executive at ONYX PHARMACEUTICALS INC (ONXX). They have executed 174 insider transactions totaling $9.2M over their tenure at the company.
Thomas G. Wiggans holds the position of Executive at ONYX PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Thomas G. Wiggans has shown a selling trading pattern, with $1.0M in total purchases and $8.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Thomas G. Wiggans was on Feb 20, 2020, when they sold $3.4M worth of DERM shares. This transaction involved 180,985 shares at $18.75 per share.
Thomas G. Wiggans currently owns 41,000 shares of ONYX PHARMACEUTICALS INC (ONXX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Thomas G. Wiggans's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Thomas G. Wiggans has 174 Form 4 filings on record as an insider at ONYX PHARMACEUTICALS INC.
Set alerts for Thomas G. Wiggans and 40,000+ other insiders.